Freke Wink
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Freke Wink has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Davy Paap
Department of Rehabilitation, University Medical Center Groningen University of Groningen Groningen The Netherlands
3 shared publications - Reinhard Bos
Department of Rheumatology, Frisius MC, Leeuwarden, the Netherlands
3 shared publications A. Spoorenberg
Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications- Ahmed Al Hasan
Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333ZA, The Netherlands, 31 0715269111
2 shared publications - Anneke Spoorenberg
University Medical Center Groningen, Rheumatology and Clinical Immnuology, Groningen, Netherlands
2 shared publications - Floor Reimann
Department of Rheumatology, Frisius Medical Centre, Leeuwarden, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e77345
Evaluating the Accuracy of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints for Triage of Musculoskeletal Diseases: Algorithm Development and Validation Study
Background: Inflammatory rheumatic diseases (IRDs) affect 5% of the general population, whereas 35% of the population experiences musculoskeletal concerns. IRDs cause early disability, reduced life expectancy, and considerable health care costs. Early diagnosis is essential to prevent long-term damage. Similarly important is the early identification of patients with musculoskeletal concerns without IRDs to prevent unnecessary health care expenses. Of the population referred to the rheumatologist, 60% have noninflammatory musculoskeletal concerns, whereas only 20% of patients with an IRD see a rheumatologist within 3 months of symptom onset. The need for digital predictive (triage) tools for rheumatic and musculoskeletal diseases led to the development of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints (FRYQ). Objective: This study aimed to assess whether the FRYQ can distinguish IRD from noninflammatory musculoskeletal concerns in general, and rheumatoid arthritis and fibromyalgia specifically, in newly referred patients. Methods: The FRYQ is an 87-item tool (20 open-ended and 67 closed-ended questions) used to triage new rheumatology patients at Frisius Medical Center in the Netherlands. We analyzed data from 2 sources: dataset A with 728 outpatient clinic patients and dataset B with 373 patients from the Joint Pain Assessment Scoring Tool study. We built a classifier using Extreme Gradient Boosting to distinguish inflammatory from noninflammatory conditions based on closed-ended questions. Using elastic net regularization, we identified the most informative questions. We evaluated classification using receiver operating characteristic curve analysis and assessed feature importance through Shapley Additive Explanation analysis. To test generalizability, we replicated our analysis on dataset B. Finally, we examined whether the questions of the FRYQ could be used to identify specific conditions beyond the general categories of IRD and non-IRD, specifically for detecting fibromyalgia and rheumatoid arthritis. Results: Feature selection reduced the questionnaire from 67 to 28 items while maintaining discriminative power. After initial development, the model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.72 (95% CI 0.67-0.78) for distinguishing inflammatory from noninflammatory conditions in an external validation set. Using a probability threshold of 0.30, the model achieved 71% sensitivity and 56% specificity on external validation. The FRYQ demonstrated stronger performance in identifying specific diagnoses such as fibromyalgia (AUC-ROC=0.81) and rheumatoid arthritis (AUC-ROC=0.77). Key discriminating features included symptom duration, pain response to movement, and anti-inflammatory medication effectiveness. Conclusions: The FRYQ effectively distinguishes inflammatory from noninflammatory rheumatic conditions before specialist consultation and shows particular strength in identifying fibromyalgia and rheumatoid arthritis. This tool could improve rheumatology triage by prioritizing referrals with high likelihood of IRD for early rheumatologist evaluation while directing other patients to appropriate alternative resources. Prospective studies are needed to determine the FRYQ’s impact on clinical outcomes and health care efficiency.
- 17 November 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e77345
Open AccessEvaluating the Accuracy of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints for Triage of Musculoskeletal Diseases: Algorithm Development and Validation Study
Background: Inflammatory rheumatic diseases (IRDs) affect 5% of the general population, whereas 35% of the population experiences musculoskeletal concerns. IRDs cause early disability, reduced life expectancy, and considerable health care costs. Early diagnosis is essential to prevent long-term damage. Similarly important is the early identification of patients with musculoskeletal concerns without IRDs to prevent unnecessary health care expenses. Of the population referred to the rheumatologist, 60% have noninflammatory musculoskeletal concerns, whereas only 20% of patients with an IRD see a rheumatologist within 3 months of symptom onset. The need for digital predictive (triage) tools for rheumatic and musculoskeletal diseases led to the development of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints (FRYQ). Objective: This study aimed to assess whether the FRYQ can distinguish IRD from noninflammatory musculoskeletal concerns in general, and rheumatoid arthritis and fibromyalgia specifically, in newly referred patients. Methods: The FRYQ is an 87-item tool (20 open-ended and 67 closed-ended questions) used to triage new rheumatology patients at Frisius Medical Center in the Netherlands. We analyzed data from 2 sources: dataset A with 728 outpatient clinic patients and dataset B with 373 patients from the Joint Pain Assessment Scoring Tool study. We built a classifier using Extreme Gradient Boosting to distinguish inflammatory from noninflammatory conditions based on closed-ended questions. Using elastic net regularization, we identified the most informative questions. We evaluated classification using receiver operating characteristic curve analysis and assessed feature importance through Shapley Additive Explanation analysis. To test generalizability, we replicated our analysis on dataset B. Finally, we examined whether the questions of the FRYQ could be used to identify specific conditions beyond the general categories of IRD and non-IRD, specifically for detecting fibromyalgia and rheumatoid arthritis. Results: Feature selection reduced the questionnaire from 67 to 28 items while maintaining discriminative power. After initial development, the model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.72 (95% CI 0.67-0.78) for distinguishing inflammatory from noninflammatory conditions in an external validation set. Using a probability threshold of 0.30, the model achieved 71% sensitivity and 56% specificity on external validation. The FRYQ demonstrated stronger performance in identifying specific diagnoses such as fibromyalgia (AUC-ROC=0.81) and rheumatoid arthritis (AUC-ROC=0.77). Key discriminating features included symptom duration, pain response to movement, and anti-inflammatory medication effectiveness. Conclusions: The FRYQ effectively distinguishes inflammatory from noninflammatory rheumatic conditions before specialist consultation and shows particular strength in identifying fibromyalgia and rheumatoid arthritis. This tool could improve rheumatology triage by prioritizing referrals with high likelihood of IRD for early rheumatologist evaluation while directing other patients to appropriate alternative resources. Prospective studies are needed to determine the FRYQ’s impact on clinical outcomes and health care efficiency.
- 7 June 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (7) , 3137-3138
Reply to “Letter to the Editor”: radiographic entheseal lesions of the pelvic region are more prevalent in radiographic axSpA than in age- and sex-matched controls and are associated with more severe spinal disease
- 7 June 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (7) , 3137-3138
Reply to “Letter to the Editor”: radiographic entheseal lesions of the pelvic region are more prevalent in radiographic axSpA than in age- and sex-matched controls and are associated with more severe spinal disease
- Open Access
- 30 January 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (3) , 1141-1150
Radiographic entheseal lesions of the pelvic region are more prevalent in radiographic axSpA than in age- and sex-matched controls and are associated with more severe spinal disease
Objectives: In axial spondyloarthritis (axSpA), entheseal involvement is common, which contributes significantly to disease burden and may also lead to structural damage. Although radiographs of the pelvis are widely available in axSpA, information on entheseal damage and associated characteristics are lacking. Therefore, we assessed the prevalence of radiographic entheseal lesions at the pelvic region in radiographic (r-) axSpA compared with controls and explored associations with patient and disease characteristics. Methods: Pelvic radiographs of 167 consecutive r-axSpA patients were randomized with 100 pelvic radiographs from age- and sex-matched controls. Radiographs were blinded for patient information and sacroiliac joints and bilaterally evaluated for erosions/cortical irregularities, enthesophytes, and calcifications by two trained readers at the greater and lesser trochanter, os ischium, and iliac crest. Results: Entheseal lesions were observed in 127 (76%) of r-axSpA patients and 58 (58%) controls. R-axSpA patients showed significantly more (bilateral) entheseal lesions than controls at all entheseal sites. Most lesions were found at the os ischium, erosions/cortical irregularities were most prevalent, and calcification was the most specific lesion in r-axSpA. Patients with lesions were significantly older, had longer symptom duration, and more severe spinal radiographic damage than patients without lesions. Enthesophytes were found significantly more often in patients with body mass index (BMI) ≥ 25. Conclusion: Structural entheseal lesions observed at pelvic radiographs are not specific but occur often in r-axSpA patients. Treating physicians should keep in mind that these entheseal lesions are associated with more severe axial disease and high BMI which may be relevant for treatment decisions. Key Points• Pelvic radiographic entheseal lesions are significantly more prevalent in r-axSpA patients than in controls.• Radiographic entheseal lesions are associated with longer symptom duration and more spinal radiographic damage.• Pelvic enthesophytes are found significantly more often in r-axSpA patients with BMI ≥ 25.
- 30 January 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (3) , 1141-1150
Open AccessRadiographic entheseal lesions of the pelvic region are more prevalent in radiographic axSpA than in age- and sex-matched controls and are associated with more severe spinal disease
Objectives: In axial spondyloarthritis (axSpA), entheseal involvement is common, which contributes significantly to disease burden and may also lead to structural damage. Although radiographs of the pelvis are widely available in axSpA, information on entheseal damage and associated characteristics are lacking. Therefore, we assessed the prevalence of radiographic entheseal lesions at the pelvic region in radiographic (r-) axSpA compared with controls and explored associations with patient and disease characteristics. Methods: Pelvic radiographs of 167 consecutive r-axSpA patients were randomized with 100 pelvic radiographs from age- and sex-matched controls. Radiographs were blinded for patient information and sacroiliac joints and bilaterally evaluated for erosions/cortical irregularities, enthesophytes, and calcifications by two trained readers at the greater and lesser trochanter, os ischium, and iliac crest. Results: Entheseal lesions were observed in 127 (76%) of r-axSpA patients and 58 (58%) controls. R-axSpA patients showed significantly more (bilateral) entheseal lesions than controls at all entheseal sites. Most lesions were found at the os ischium, erosions/cortical irregularities were most prevalent, and calcification was the most specific lesion in r-axSpA. Patients with lesions were significantly older, had longer symptom duration, and more severe spinal radiographic damage than patients without lesions. Enthesophytes were found significantly more often in patients with body mass index (BMI) ≥ 25. Conclusion: Structural entheseal lesions observed at pelvic radiographs are not specific but occur often in r-axSpA patients. Treating physicians should keep in mind that these entheseal lesions are associated with more severe axial disease and high BMI which may be relevant for treatment decisions. Key Points• Pelvic radiographic entheseal lesions are significantly more prevalent in r-axSpA patients than in controls.• Radiographic entheseal lesions are associated with longer symptom duration and more spinal radiographic damage.• Pelvic enthesophytes are found significantly more often in r-axSpA patients with BMI ≥ 25.
- Open Access
Value of the central sensitisation inventory in patients with axial spondyloarthritis
Background In many patients with axial spondyloarthritis (axSpA), pain persists despite anti-inflammatory medication. Quantitative sensory testing (QST) indirectly assesses altered somatosensory function, though its clinical practicality is limited. The Central Sensitisation Inventory (CSI) could be an alternative in the initial assessment of central sensitisation (CS). This study aimed to investigate the value of the CSI in evaluating CS in patients with axSpA by (1) assessing somatosensory function related to CS with QST and (2) exploring associations between CSI, QST, patient and disease characteristics and pain-related psychosocial factors. Methods Consecutive outpatients from the Groningen Leeuwarden AxSpA cohort underwent QST, including pressure pain threshold (PPT), temporal summation (TS) and conditioned pain modulation (CPM). Participants completed questionnaires assessing CS (CSI), illness perception (Revised Illness Perception Questionnaire, IPQ-R), pain-related worrying (Pain Catastrophising Scale, PCS), fatigue (Modified Fatigue Impact Scale, MFIS), anxiety/depression (Hospital Anxiety and Depression Scale, HADS) and coping. QST measurements were stratified for CSI≥40. Results 201 patients with axSpA were included; 63% male, 64% radiographic axSpA, median symptom duration 12 years (IQR 5–24), mean Axial Spondyloarthritis Disease Activity Score 2.1±1.0. Patients with CSI≥40 had significantly lower PPTs and higher TS than CSIConclusion In this large cross-sectional study in patients with axSpA, the CSI appears as a useful initial CS assessment questionnaire. When CSI scores indicate CS, considering pain-related psychosocial factors is important. These results emphasise the need for a biopsychosocial approach to manage chronic pain in patients with axSpA.
Open AccessValue of the central sensitisation inventory in patients with axial spondyloarthritis
Background In many patients with axial spondyloarthritis (axSpA), pain persists despite anti-inflammatory medication. Quantitative sensory testing (QST) indirectly assesses altered somatosensory function, though its clinical practicality is limited. The Central Sensitisation Inventory (CSI) could be an alternative in the initial assessment of central sensitisation (CS). This study aimed to investigate the value of the CSI in evaluating CS in patients with axSpA by (1) assessing somatosensory function related to CS with QST and (2) exploring associations between CSI, QST, patient and disease characteristics and pain-related psychosocial factors. Methods Consecutive outpatients from the Groningen Leeuwarden AxSpA cohort underwent QST, including pressure pain threshold (PPT), temporal summation (TS) and conditioned pain modulation (CPM). Participants completed questionnaires assessing CS (CSI), illness perception (Revised Illness Perception Questionnaire, IPQ-R), pain-related worrying (Pain Catastrophising Scale, PCS), fatigue (Modified Fatigue Impact Scale, MFIS), anxiety/depression (Hospital Anxiety and Depression Scale, HADS) and coping. QST measurements were stratified for CSI≥40. Results 201 patients with axSpA were included; 63% male, 64% radiographic axSpA, median symptom duration 12 years (IQR 5–24), mean Axial Spondyloarthritis Disease Activity Score 2.1±1.0. Patients with CSI≥40 had significantly lower PPTs and higher TS than CSIConclusion In this large cross-sectional study in patients with axSpA, the CSI appears as a useful initial CS assessment questionnaire. When CSI scores indicate CS, considering pain-related psychosocial factors is important. These results emphasise the need for a biopsychosocial approach to manage chronic pain in patients with axSpA.
- Open Access
- 31 July 2023
- Published by Springer Nature in Rheumatology and Therapy
- Vol. 10 (5) , 1349-1368
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Introduction Within the EULAR recommendations, patient education (PE) is stated as the basis of the management of axial spondyloarthritis (axSpA). However, educational needs are scarcely qualitatively studied in axSpA. Therefore, we aimed to explore experiences and needs of PE in patients with axSpA. Methods A phenomenological approach was used, with semi-structured in-depth interviews with patients with axSpA including broad variation in characteristics. Thematic analysis was applied. To enhance credibility, data saturation, research triangulation, peer debriefing, member checking, theoretical notes, and bracketing were performed. Results Three interrelated themes regarding PE were identified from 20 interviews: illness perception, content, and ‘availability’. Illness perception affects how patients experience and process PE, which consequently influences coping strategies. Prognosis, treatment, and coaching to self-management were identified as the most important content of PE. Regarding ‘availability’, face-to-face PE is preferred for exploring needs, supplemented by self-education, which can be freely applied. Additionally, sufficient time and a comprehensible amount of information were important and participants emphasized the need for axSpA-tailored information for relatives and friends. Participants reported a trusting patient–healthcare provider (HCP) relationship, and multidisciplinary and interdisciplinary attunement between HCPs as prerequisites for effective PE. Conclusions This first qualitative study exploring patients’ experiences and needs of PE in axSpA revealed that prognosis, treatment, and coaching to self-management are important regarding content, and the combination of face-to-face contact and self-education the preferred modalities. It seems essential that patients’ illness perceptions are taken into account for effective PE. These results add relevant insights for future PE guidelines in axSpA.
- 31 July 2023
- Published by Springer Nature in Rheumatology and Therapy
- Vol. 10 (5) , 1349-1368
Open AccessPatients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Introduction Within the EULAR recommendations, patient education (PE) is stated as the basis of the management of axial spondyloarthritis (axSpA). However, educational needs are scarcely qualitatively studied in axSpA. Therefore, we aimed to explore experiences and needs of PE in patients with axSpA. Methods A phenomenological approach was used, with semi-structured in-depth interviews with patients with axSpA including broad variation in characteristics. Thematic analysis was applied. To enhance credibility, data saturation, research triangulation, peer debriefing, member checking, theoretical notes, and bracketing were performed. Results Three interrelated themes regarding PE were identified from 20 interviews: illness perception, content, and ‘availability’. Illness perception affects how patients experience and process PE, which consequently influences coping strategies. Prognosis, treatment, and coaching to self-management were identified as the most important content of PE. Regarding ‘availability’, face-to-face PE is preferred for exploring needs, supplemented by self-education, which can be freely applied. Additionally, sufficient time and a comprehensible amount of information were important and participants emphasized the need for axSpA-tailored information for relatives and friends. Participants reported a trusting patient–healthcare provider (HCP) relationship, and multidisciplinary and interdisciplinary attunement between HCPs as prerequisites for effective PE. Conclusions This first qualitative study exploring patients’ experiences and needs of PE in axSpA revealed that prognosis, treatment, and coaching to self-management are important regarding content, and the combination of face-to-face contact and self-education the preferred modalities. It seems essential that patients’ illness perceptions are taken into account for effective PE. These results add relevant insights for future PE guidelines in axSpA.
- 27 January 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (11) , 2019-2026
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry
The Handscan is a novel objective optical imaging device for disease follow-up and management in rheumatoid arthritis patients. We aim to examine the association between the baseline outcomes of the Handscan, disease activity levels and joint swelling. The Handscan measures differences in laser light absorption between joints of fingers and wrists and adjacent reference tissue, indicating the presence or absence of inflammation. The device gives an optical spectral transmission (OST) index per joint. The average of these indices is represented in the total optical score (TOS). Associations between TOS and DAS28 at subject level and OST and swelling at joint level were examined. 484 RA patients were included. Compared to patients with high disease activity (defined by DAS28), TOS was significantly lower in patients with moderate (estimated coefficient B: − 7.09, P < 0.001), low disease activity (B: − 6.99, P < 0.001) and patients in remission (B: − 7.72, P < 0.001) but could not distinguish between the latter three disease states. TOS was significantly lower in females (B: − 3.2, P < 0.001). OST was significantly higher in swollen than non-swollen joints (B: 0.28, P < 0.001). TOS was significantly higher in patients with high disease activity than in those in remission or with low and moderate disease activity. The difference in TOS between males and females should be accounted for in the interpretation of this outcome. The OST at joint level discriminates swollen from non-swollen joints and could be a more promising tool than the overall optical activity reflected in TOS.
- 27 January 2022
- Published by Springer Nature in Rheumatology International
- Vol. 42 (11) , 2019-2026
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry
The Handscan is a novel objective optical imaging device for disease follow-up and management in rheumatoid arthritis patients. We aim to examine the association between the baseline outcomes of the Handscan, disease activity levels and joint swelling. The Handscan measures differences in laser light absorption between joints of fingers and wrists and adjacent reference tissue, indicating the presence or absence of inflammation. The device gives an optical spectral transmission (OST) index per joint. The average of these indices is represented in the total optical score (TOS). Associations between TOS and DAS28 at subject level and OST and swelling at joint level were examined. 484 RA patients were included. Compared to patients with high disease activity (defined by DAS28), TOS was significantly lower in patients with moderate (estimated coefficient B: − 7.09, P < 0.001), low disease activity (B: − 6.99, P < 0.001) and patients in remission (B: − 7.72, P < 0.001) but could not distinguish between the latter three disease states. TOS was significantly lower in females (B: − 3.2, P < 0.001). OST was significantly higher in swollen than non-swollen joints (B: 0.28, P < 0.001). TOS was significantly higher in patients with high disease activity than in those in remission or with low and moderate disease activity. The difference in TOS between males and females should be accounted for in the interpretation of this outcome. The OST at joint level discriminates swollen from non-swollen joints and could be a more promising tool than the overall optical activity reflected in TOS.
- Open Access
- 1 June 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (Suppl 1) , 54
OP0080 CENTRAL SENSITIZATION AND ILLNESS PERCEPTIONS SHOULD BE TAKEN INTO ACCOUNT WHEN INTERPRETING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Background: Up to 40% of ankylosing spondylitis patients report persistently high pain scores of >4 (scale of 0-10) even after responding to long-term TNF-alpha blocking therapy.[1] In other rheumatic diseases, nociplastic pain (due to altered functioning of the nervous system leading to peripheral and central sensitization) is common.[2] In axial spondyloarthritis (axSpA), patient illness and pain perceptions were shown to influence disease outcome.[3] Therefore, we hypothesized that central sensitization and patients’ illness perceptions are associated with persistently high disease activity in axSpA. Objectives: To investigate to what extent central sensitization, pain catastrophizing and patients’ perceptions play a role in axSpA and to explore associations with disease activity. Methods: Between April and September 2019, consecutive outpatients from the Groningen Leeuwarden axSpA (GLAS) cohort,[4] an ongoing large prospective cohort, were included in this study. Besides the standardized assessments, patients filled out three additional questionnaires: Central Sensitization Inventory (CSI), Pain Catastrophizing Scale (PCS) and Revised Illness Perception Questionnaire (IPQ-R). Univariable and multivariable linear regression analyses were used to investigate the association of CSI, PCS and each of the eight subscales of the IPQ-R, and disease activity assessments ASDAS-CRP, BASDAI, and CRP. We corrected for the following potential confounders: gender, symptom duration, BMI, educational level, smoking status and HLA-B27 status. Results: Of 171 included patients, 58% were male, 79% were HLA-B27 positive, median symptom duration was 21 (IQR 10-32), mean ASDAS-CRP 2.1 ± 1.0, mean BASDAI 3.9 ± 2.2 and median CRP 2.9 (IQR 1.2-6.3). Mean CSI score was 37.8 ± 14.1 (scale of 0-100), and 44% of patients scored ≥40 on the CSI.[5] Median PCS score was 15 (IQR 7-22) (scale of 0-52), median IPQ-R illness identity subscore 3 (IQR 2-4) (scale of 0-14) and mean IPQ-R treatment control subscore 18.1 ± 3.4 (scale of 5-25). In univariable regression analysis, CSI and PCS scores and IPQ-R subscores all showed significant associations with ASDAS-CRP, and all except the IPQ-R subscale personal control showed significant associations with BASDAI. Only IPQ-R treatment control was significantly associated with CRP. Central sensitization, two IPQ-R subscales (perceived treatment control and the number of symptoms patients attributed to their axSpA: illness identity) and BMI were independently associated with disease activity assessments BASDAI (R2=0.46) and ASDAS-CRP (R2=0.36) (Figure 1). Conclusion: In this axSpA population with long-term disease, 44% scored above the CSI cutoff point of 40, indicating a high probability of central sensitization. CSI score, illness identity and treatment control were independently associated with disease activity assessments. References: [1]Arends S et al. Clin Exp Rheumatol 2017;35(1):61-8. [2]Meeus M et al. Semin Arthritis Rheum 2012;41(4):556-67. [3]Van Lunteren M et al. Arthritis Care Res (Hoboken) 2018;70(12):1829-39. [4]Arends S et al. Arthritis Res Ther 2011;13(3):R94. [5]Neblett R et al. J Pain 2013;14(5):438-45. Disclosure of Interests: Stan Kieskamp: None declared, Davy Paap: None declared, Marlies Carbo: None declared, Freke Wink Consultant of: Abbvie, Janssen, Reinhard Bos: None declared, Hendrika Bootsma Grant/research support from: Unrestricted grants from Bristol-Myers Squibb and Roche, Consultant of: Consultant for Bristol-Myers Squibb, Roche, Novartis, Medimmune, Union Chimique Belge, Speakers bureau: Speaker for Bristol-Myers Squibb and Novartis., Suzanne Arends Grant/research support from: Grant/research support from Pfizer, Anneke Spoorenberg: None declared
- 1 June 2020
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (Suppl 1) , 54
Open AccessOP0080 CENTRAL SENSITIZATION AND ILLNESS PERCEPTIONS SHOULD BE TAKEN INTO ACCOUNT WHEN INTERPRETING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Background: Up to 40% of ankylosing spondylitis patients report persistently high pain scores of >4 (scale of 0-10) even after responding to long-term TNF-alpha blocking therapy.[1] In other rheumatic diseases, nociplastic pain (due to altered functioning of the nervous system leading to peripheral and central sensitization) is common.[2] In axial spondyloarthritis (axSpA), patient illness and pain perceptions were shown to influence disease outcome.[3] Therefore, we hypothesized that central sensitization and patients’ illness perceptions are associated with persistently high disease activity in axSpA. Objectives: To investigate to what extent central sensitization, pain catastrophizing and patients’ perceptions play a role in axSpA and to explore associations with disease activity. Methods: Between April and September 2019, consecutive outpatients from the Groningen Leeuwarden axSpA (GLAS) cohort,[4] an ongoing large prospective cohort, were included in this study. Besides the standardized assessments, patients filled out three additional questionnaires: Central Sensitization Inventory (CSI), Pain Catastrophizing Scale (PCS) and Revised Illness Perception Questionnaire (IPQ-R). Univariable and multivariable linear regression analyses were used to investigate the association of CSI, PCS and each of the eight subscales of the IPQ-R, and disease activity assessments ASDAS-CRP, BASDAI, and CRP. We corrected for the following potential confounders: gender, symptom duration, BMI, educational level, smoking status and HLA-B27 status. Results: Of 171 included patients, 58% were male, 79% were HLA-B27 positive, median symptom duration was 21 (IQR 10-32), mean ASDAS-CRP 2.1 ± 1.0, mean BASDAI 3.9 ± 2.2 and median CRP 2.9 (IQR 1.2-6.3). Mean CSI score was 37.8 ± 14.1 (scale of 0-100), and 44% of patients scored ≥40 on the CSI.[5] Median PCS score was 15 (IQR 7-22) (scale of 0-52), median IPQ-R illness identity subscore 3 (IQR 2-4) (scale of 0-14) and mean IPQ-R treatment control subscore 18.1 ± 3.4 (scale of 5-25). In univariable regression analysis, CSI and PCS scores and IPQ-R subscores all showed significant associations with ASDAS-CRP, and all except the IPQ-R subscale personal control showed significant associations with BASDAI. Only IPQ-R treatment control was significantly associated with CRP. Central sensitization, two IPQ-R subscales (perceived treatment control and the number of symptoms patients attributed to their axSpA: illness identity) and BMI were independently associated with disease activity assessments BASDAI (R2=0.46) and ASDAS-CRP (R2=0.36) (Figure 1). Conclusion: In this axSpA population with long-term disease, 44% scored above the CSI cutoff point of 40, indicating a high probability of central sensitization. CSI score, illness identity and treatment control were independently associated with disease activity assessments. References: [1]Arends S et al. Clin Exp Rheumatol 2017;35(1):61-8. [2]Meeus M et al. Semin Arthritis Rheum 2012;41(4):556-67. [3]Van Lunteren M et al. Arthritis Care Res (Hoboken) 2018;70(12):1829-39. [4]Arends S et al. Arthritis Res Ther 2011;13(3):R94. [5]Neblett R et al. J Pain 2013;14(5):438-45. Disclosure of Interests: Stan Kieskamp: None declared, Davy Paap: None declared, Marlies Carbo: None declared, Freke Wink Consultant of: Abbvie, Janssen, Reinhard Bos: None declared, Hendrika Bootsma Grant/research support from: Unrestricted grants from Bristol-Myers Squibb and Roche, Consultant of: Consultant for Bristol-Myers Squibb, Roche, Novartis, Medimmune, Union Chimique Belge, Speakers bureau: Speaker for Bristol-Myers Squibb and Novartis., Suzanne Arends Grant/research support from: Grant/research support from Pfizer, Anneke Spoorenberg: None declared